Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Investigators described a syndrome of cholangiopathy in patients recovering from severe COVID-19 with abnormal liver tests and bile duct injury.
Truseltiq is an orally administered, ATP-competitive, tyrosine kinase inhibitor of FGFR.
The FDA has identified 25 cases of serious liver injury leading to liver decompensation or liver failure associated with Ocaliva in PBC patients with compensated or decompensated cirrhosis.
Researchers analyzed the genomes of children with chronic cholestasis for gene variants not typically associated with liver disease.
Researchers aimed to compare clinical characteristics of patients with IgG4-SC and AIP vs without.
This study evaluated the safety, feasibility, and QoL of patients after endoscopic ultrasonography-guided biliary drainage with lumen-apposing metal stents, after failed ERCP.
The FITCH trial was conducted to evaluate the effect of bezafibrate on pruritus in patients with fibrosing cholangiopathies (PSC, PBC, and SSC).
When diagnosing indeterminate biliary strictures, digital single-operator cholangioscopy (DSOC)-guided biopsy has demonstrated safety, efficacy, and higher sensitivity than standard endoscopic retrograde cholangiopancreatography.
Study investigators concluded that although the optimum treatment course for common bile duct stones has not yet been determined, “ERCP for CBD stone clearance involves multiple interventions, prolonged treatment, causes post procedure morbidity and high treatment costs.
Nearly half of patients with early-stage PBC progress to a more severe stage within 5 years. Progression is associated with increased risk of a clinical event, so surveillance is important for patients with early-stage PBC.
Researchers conducted a retrospective cohort study to determine the clinical features of pediatric patients with PSC in a Japanese cohort to evaluate long-term outcomes. They discovered that primary sclerosing cholangitis (PSC)-autoimmune hepatitis overlap is the primary phenotype linked to poor long-term outcomes.
The researchers observed an increased risk for acute gallbladder or biliary disease with liraglutide versus placebo (hazard ratio, 1.60). Similar findings were seen for each of the four categories of gallbladder- or biliary tract-related events (uncomplicated gallbladder stones, complicated gallbladder stones, cholecystitis with/without gallbladder stones, and biliary obstruction).
At a routine follow-up visit at the clinic a month prior, the patient reported consuming at least 2 bags of unpeeled lemons per day.